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Summary. The mesenteric panniculitis is a rare form of inflammation that mainly involves the mesenteric adi-
pose tissue. The etiology remains unknown and the disease has been associated with various conditions such as 
cancer, abdominal trauma, previous surgery, autoimmune diseases and obesity. Mesenteric panniculitis can be 
divided into two main groups: the mesenteric panniculitis with only the inflammation and degeneration of the 
mesenteric fat, and the retractile panniculitis, mainly fibrotic, with retraction of the surrounding structures. 
From a radiological point of view, there are two main signs: the fat ring sign, which is the presence of normal 
fat around vessels and lymph nodes, and the pseudocapsula around the lesion. In this paper, we present the 
imaging and clinical features of mesenteric panniculits with particular reference to the differential diagnosis 
and the possible etiological associations. (www.actabiomedica.it)
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Introduction
The mesenteric panniculitis is a rare and chronic 
inflammatory disease which involves primarly the mes-
entery and rarely other sites like omentum and meso-
colon. The etiology of the disease remains understood 
but it recurs in association with various conditions 
like abdominal surgery, mesenteric ischemia, trauma, 
obesity, abdominal and extra-abdominal cancer and 
abdominal inflammatory disease. The disease is often 
asymptomatic but it may produce symptoms like ab-
dominal pain, constipation or diarrhoea, and dyspep-
sia. Sometimes it appears as an abdominal mass and 
may produce bowel obstruction or ischemia, requiring 
urgent surgery. The two main form of mesenteric pan-
niculitis are: the classical type with inflammation, ne-
crosis and degeneration of fat, and the retractile pan-
niculitis with a prominent fibrosis of mesentery with 
rectraction of the surrounding structures. The diagno-
sis is mainly radiological, and the computed tomog-
raphy (CT) and magnetic resonance imaging (MRI) 
are the most useful methods to detect the disease. To 
assess the diagnosis, in general, the radiologist must 
consider some morphological manifestations like the 
presence of a circumscribed mass in mesentery with 
a fibrotic pseudocapsule, vessels and lymph nodes in-
side the mass and a preserving rim of fat around them, 
the so-called fat ring sign. However, the mass with a 
prominent fibrotic component with o without retrac-
tion of the surrounding structures may appear as a 
solid mass.
In this paper, we aim to review the clinical and ra-
diological manifestations of the disease on the basis of 
our direct experience and the literature data.  Indeed, 
we want to present some ideas on the etiology of this 
disease.
Clinical manifestations and associated disorders
The mesenteric panniculitis is a non specific in-
flammatory process of mesentery which produces 
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degeneration, necrosis and fibrotic proliferation of 
mesenteric fat (1). The mesenteric panniculitis rarely 
involves the omentum, the peritoneum of the large in-
testine, the retroperitoneal and pelvic fat (2). It is more 
common in men, with a male-to-female ratio of 2-3:1, 
and it is more common in Caucasian men (3). The dis-
ease is more frequent between the 6th and 7th decades 
of life (4), but some pediatric cases were described (5). 
The mesenteric panniculitis is a rare disease and the 
prevalence reported in the scientific literature ranges 
between 0,16-3,3% (6).
The mesenteric panniculitis is usually asympto-
matic and when symptomatic, the clinical manifesta-
tions are not specific, depending on the size and loca-
tion of the mass and its relationship with the bowel, 
vessels and lymphatics (7). However, the mesenteric 
panniculitis may be the cause of abdominal pain, nau-
sea, vomiting, diarrhoea, constipation, fever, weight 
loss, chylous ascites (8). In a recent clinical study, the 
major complaint was abdominal pain, which was pre-
sent in the 72% of patients with mesenteric pannicu-
litis. Other mesenteric panniculitis related symptoms 
were nausea and vomiting and diarrhoea (9). Akram et 
al. reported in a case series of 92 patients that the most 
common symptoms were abdominal pain (70%), bloat-
ing and distention (26%), diarrhoea (25%) and weight 
loss (23%). Only 10% were asymptomatic at the time 
of diagnosis (10). In a study of Nyberg et al. 5 of the 27 
patients were asymptomatic, 13 had symptoms without 
signs of systemic inflammation, five were symptomat-
ic with signs of systemic inflammation and four had 
severe disease with multiple hospitalisation, chronic, 
refractory or complicated disease. However, the 4 
patients with high clinical score had a concomitant 
chronic disease (Bechet’s, Crohn’s, psoriasis arthritis 
and hereditary spastic paraparesis) and for 3 of them, 
the concomitant disease caused the major morbidity. 
In the same study the abdominal pain was reported by 
21 patients and was the most common symptom. Six 
patients specifically reported symptoms at night and 
symptoms related to body posture. In addition, nausea, 
weight loss, flatulence and diarrhoea were reported. 
Tenderness in the left hypochondrium and sometimes 
a tender palpable mass were described. Most sympto-
matic patients had chronic discomfort but some pa-
tients had acute episodes with intense pain (11). 
In mesenteric panniculitis patients, the blood tests 
results are often normal. The erythrocyte sedimenta-
tion rate and C-reactive protein level may be elevated 
in response to the inflammatory state and may serve 
as markers of response to medical therapy (8). The 
course of the disease is usually benign but sometimes 
the mesenteric panniculitis may be the cause of bowel 
perforation, bowel occlusion ( small bowel obstruction 
was present in 24% of patients in the study of Akram 
et alt.), bowel ischemia and renal failure due to ure-
teral stenosis and may be therefore a potentially lethal 
disease requiring urgent medical or surgical treatment 
(10, 12, 13). The correct evaluation of the symptoma-
tology, therefore, appears to be a fundamental step in 
the clinical and therapeutic framework of this disease 
to identify the most critical situations.
The mesenteric panniculitis is a disease with an 
understood etiology but, in the scientific literature, it 
was associated with various conditions such as mesen-
teric thrombosis, mesenteric arteriopathy, autoimmune 
disease, such as IgG4 related disease, pancreatitis, uri-
nary system diasease and infection (14, 15). Other fac-
tors, such as urinary gallstones, abdominal aortic aneu-
rysm, prior abdominal trauma, peptic ulcer, or chylous 
ascitis, have also been linked to this disease (16).
However, the most common conditions associated 
with mesenteric panniculitis are the abdominal surgery 
and cancer (3). The most common types of cancer as-
sociated with mesenteric pannicultis are the abdominal 
lymphoma, melanoma, colon carcinoma and prostate 
cancer (3, 17). Various studies have attempted to un-
derstand the correlation between mesenteric pannicu-
litis and cancer. In particular, a possible paraneoplastic 
nature of mesenteric panniculitis was assessed, but this 
association is widely discussed. In an analysis by Göge-
bakan Ö et al., the authors rejected the hypothesis of a 
paraneoplastic etiology of the disease (18). Buchwald 
carried out a cohort study in which no statistically sig-
nificant association was found between the course of 
mesenteric panniculitis and cancer, considering the 
pathology as an epiphenomenon and not as a true 
paraneoplastic event. In fact, one of the reasons why 
CT and MRI are most frequently required is neoplas-
tic disease, which could explain the high incidence of 
mesenteritis in cancer patients (19). However, in the 
Van Puttie study, a significantly higher prevalence of 
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neoplastic disease was found in patients with mesen-
teric panniculitis (20). The same authors reported an 
increase in the prevalence and risk of future cancer 
during a 5-year follow-up (20), while Scheer described 
a five-fold higher risk of malignancy in the presence 
of mesenteric panniculitis (21). It has also been pro-
posed that mesenteric panniculitis may be caused by 
the ischemic or inflammatory effect of chemotherapy 
(22). Among tumors, is interesting the association 
with lymphomas. Various authors have hemphasized 
the correlation between abdominal lymphomas, which 
is the most frequent neoplasia with an intraperitoneal 
and extraperitoneal localization, and the mesenteric 
panniculitis. In a study of Khasminsky et al., the au-
thors, on a total of 166 patients who were diagnosed 
with non-Hodgkin lymphoma over a period of 5 years, 
found a prevalence of mesenteric panniculitis among 
patients with lymphoma of 1.8%, which corresponds 
to the range of its prevalence in the general popula-
tion (23). However, Coulier B. et al. reported that 
the abdominal lymphoma occurs in the 15,1% of pa-
tients with a history of cancer while in the experience 
of Daskalogiannaki M. et al. the association between 
mesenteric panniculitis and lymphoma was found in 
25 of 88 patients. Interesting, Fatahi Bandpey et al. 
reported that 16 (33%) of the 48 analyzed patients 
with abdominal lymphoma showed mesenteric pan-
niculitis: 7 of them (43.75%) at the time of diagnosis 
and the remaining 9 patients (56.25%) later. Of the 9 
patients who developed mesenteric panniculitis during 
the disease evolution, R-CHOP (55.55%) and ABVD 
(33.33%) were the most frequent regimens associated 
with the onset of the diasease. Of the 7 patients with 
the mesenteric panniculitis at the diagnosis, the fol-
licular non-Hodgkin lymphoma (42.9%), and the 
Hodgkin lymphoma (28.6%) were the most common 
lymphoma types associated with the mesenteric pan-
niculitis (4, 15, 24).
The most common surgical treatments associated 
with mesenteric panniculitis are the cholecystectomy, 
appendicectomy, hysterectomy and colectomy (25). 
Emory reported a series in which 84% of patients had 
a history of trauma or abdominal surgery (8). Durst et 
al. stated that the recent surgery was related to 17% 
of its cases, constituting a predisposing factor (25, 
26). In recent reports the mesenteric panniculitis was 
observed in patients treated with bariatric surgery. 
In these patients the mesenteric panniculitis was ob-
served after surgery and the disease may be considered 
a truly surgical complication (27, 28).
In addition, Mahafza et al. reported a prior his-
tory of abdominal surgery in 44 (49%) of the 90 pa-
tients with MP of whom 9 (10%) had more than one 
abdomino-pelvic surgery. The prevalence of the disease 
in patients with a history of previous abdominal sur-
gery was 9.2% (44/476) while it was of 1.1% (46/4282) 
in patients without prior abdomino-pelvic surgery, a 
statistically highly significant difference (p=0.0001) 
(29).
In our clinical experience, the mesenteric pan-
niculitis was associated with abdominal cancer, mainly 
lymphoma, colon cancer and genito-urinary system 
cancer, abdominal surgery, urinary lithiasis and ab-
dominal inflammatory conditions, like reported in lit-
erature.   
At this point it is interesting to discuss these pos-
sible etiological correlations. The mesenteric pannicu-
litis is a chronic inflammatory disease of the mesen-
tery whose cause is little known today. If it is true that 
mesenteric panniculitis is occasionally diagnosed with 
radiological methods and that most radiological com-
puted tomography and magnetic resonance  examina-
tions of the abdomen are carried out in patients with a 
history of cancer or abdominal surgery, for which mes-
enteric panniculitis could be a simple epiphenomenon 
without any etiological correlation with the aforemen-
tioned conditions, it is also true that mesenteric pan-
niculitis is rarely diagnosed in patients who have not 
a known pathology causing mesenteric inflammation. 
In fact, it is reasonable to think that benign or malig-
nant conditions such as neoplasms, abdominal surgery, 
inflammatory processes of the abdomen, can cause a 
chronic fibro-inflammation of the mesentery. In these 
cases we could speak of secondary forms of mesenteric 
panniculitis. This could have important repercussions 
in the diagnosis and treatment of the disease because 
abdominal symptoms secondary to chemotherapy, ra-
diotherapy, abdominal surgery or abdominal inflam-
matory process could still suspect an underlying mes-
enteric panniculitis, as a subacute or late manifestation 
or complication. This reasoning does not arise only 
from the experience of the authors but also from the 
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literature. The already exposed correlation with radio-
chemotherapy in tumors could be an example such 
as the rapidly progressive and aggressive panniculitis 
forms found after bariatric surgery in two cases or the 
IgG4 found in the histological specimens of mesen-
teric panniculitis associated with IgG4 related disease 
(24, 27, 30, 31) (Figure 1-2).
Treatment
About the treatment, there is no consensus among 
the authors. The choice of treatment depends on the 
symptomatology. If the disease is asymptomatic, medi-
cal treatment is usually not carried out. If the disease 
produces abdominal symptoms, usually abdominal 
pain or dyspepsia, medical treatment is the first choice 
to reduce the symptomatology and/or to produce a re-
gression of the disease. When the mesenteric pannicu-
litis is complicated by intestinal obstruction, ischemia 
or perforation, or when the medical treatment fails, the 
mesenteric mass and/or the adjacent bowel may be re-
moved. Surgery should, however, only be performed 
in patients who really need it because it involves the 
removal of the mesenteric mass and the bowel affected 
by the pathological process. In fact, the surgical re-
moval can be difficult due to the extent of the disease 
and the vascular obstruction of the mesenteric vessels. 
We must also consider the extension of the intestinal 
tract involved, because the removal of a long portion of 
small intestine can expose these patients to short bow-
el syndrome. Therefore, in the absence of the afore-
mentioned requirements that make the patient eligible 
for surgery, the surgical approach should be limited to 
performing a biopsy.
Regarding the medical therapy, the most common 
drugs used are the tamoxifen, prednisone, colchicine, 
azathioprine and other immunosoppressive drugs, and 
thalidomide. In particular, corticosteroids have been 
used as first-line therapy while immunosuppressive 
drugs have been used as second-line therapy in cases 
of symptomatic recurrence or if the first line therapy 
failed. However, Sahin et al. reported a good clini-
cal response in patients with mesenteric panniculitis, 
unrelated with other clinical conditions, treated with 
NSAIDs and/or antibiotics, that, in these patients, 
Figure 1. A case of abdominal lymphoma. The CT image shows 
multiple, large bulky masses in the abdomen due to coalescent 
lymph nodes
Figure 2. In the same patient of figure 1, the CT shows the 
presence of a mesenteric mass after the treatment for lympho-
ma. The lesion was stable at subsequent controls and this mass 
could be considered a secondary mesenteric panniculitis
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could indicate that the mesenteric panniculitis is of 
infectious origin. The response of the disease to treat-
ment and its course is usually good and the progression 
is rare. In the study of Akram et al., 44 symptomatic 
patients of the 92 considered in the study received a 
treatment. Treatment included medical therapy alone 
in 26% of patients, surgery alone (partial or complete 
resection of the mesenteric mass and adiacent small 
bowel) in 13%, surgery followed by medical therapy 
in 9% of patients. Ten percent responded to surgery 
alone, 20% responded to medicl treatment and surgery, 
and 38% responded to medical therapy alone. The pro-
gression of the disease was observed only in 6 patients 
who received only the medical therapy.
Daskalogiannaki et al. reported the radiological 
stability of the disease in 20 of 21 mesenteric pan-
niculitis patients during a follow-up period between 
5 months and 3 years. Of these patients, 18 had an 
underlying malignancy and the mesenteric panniculi-
tis was not treated; three patients without malignancy 
received a medical treatment with a clinical response 
in two patients and intermittent symptoms persisted 
in the third patient but the mass remained the same 
on CT images. In one patients, the authors observed a 
slight increase in the size of the fatty mass with mild 
thickening of the stripe, which was interpreted as a 
progression of the disease. Issa et al., reported the cases 
of two patients with symptomatic mesenteric pannic-
ulitis treated with prednisone with complete clinical 
and radiological response. The study of Buchwald et 
al. showed that mesenteric panniculitis was stable in 
80.9% of patients and regress in the 19,1% of patients 
on CT follow-up.
In general, the mesenteric panniculitis is often 
asymptomatic and it not require a treatment and re-
main stable. The treatment is reserved for patients who 
have abdominal symptoms and the response to treat-
ment, in our opinion, must be assessed with clinical 
and radiological scores. The response to treatment ap-
pears to be releated with the presentation of a symp-
tomatic mesenteric panniculitis: if the disease shows 
a slight abdominal symptomatology the prognosis is 
good as well as the clinical response to therapy whereas 
worst outcomes and death may occur in patients with 
acute abdominal complications requiring urgent sur-
gery (3, 10, 15, 19, 25, 27, 32-35).
Imaging
The radiological features of the mesenteric pan-
niculitis are well known in medical literature and the 
radiological examinations are the keys to identify the 
mesenteric panniculitis. In most studies, the mesenter-
ic panniculitis has been described on CT images. The 
mesenteric panniculitis is usually described as a mass 
heterogeneous, solitary, localized mainly in the mes-
entery, usually left oriented, with delocalization of the 
small intestine and surrounding structures. The two 
main radiological signs are the fat ring sign, described 
as a ring of normal fat around vessels and lymph nodes 
and the pseudocapsule sign, defined as a thin, usu-
ally <3 mm, fibrotic rim around the mass. These two 
signs are considered the radiological hallmarks of the 
mesenteric panniculitis. They recur in 70%-92% and 
50%-60% of the patients, respectively. The mesenteric 
vessels often appear engulfed and some cases of mes-
enteric vessels thrombosis have been described (Figure 
3-4).  ystic components have also been described and 
may be the result of lymphatic or venous obstruction as 
well as necrotic change (33, 36, 37). Calcifications may 
be present, often in the necrotic portion of the mass. 
The mesenteric panniculitis is a disease of the mesen-
tery, but it may involve the pancreatic region and the 
porta hepatis (33), the omentum and other part of the 
peritoneum such as the mesocolon (38, 39).
The mesenteric panniculitis is a chronic inflam-
matory disease of mesentery with a variable fibrotic 
component that evolves from the chronic inflamma-
tion of the mesenteric fat and may produce a retraction 
of the surrounding structures. In this case, we should 
use the term of retractile panniculitis. 
About this, three progressive pathological stages 
of mesenteric panniculitis have been proposed in lit-
erature.  In the first phase the mesenteric fat undergoes 
a process of diffuse degeneration (lipodystrophy pan-
niculitis), which results in an inflammatory form (mes-
enteric panniculitis) and finally in a fibrotic form with 
retraction of the intestine and surrounding structures 
(retractable panniculitis). However, some authors used 
only the term mesenteric panniculitis to indicate the de-
generative-inflammatory form and the term retractable 
panniculitis to identify the fibrotic form complicated by 
retraction of the surrounding structures (8, 15). This di-
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vision is, in our opinion, very important. The retractile 
form may be quite different from the “classical” mesen-
teric panniculitis also on images. The fibrotic compo-
nent may be variable and the rectractile form may have 
the appearence of a mass with a partial fibrotic compo-
nent or a predominantly solid and fibrotic mass without 
the pseudocapsule and fat ring sign. The fibrotic compo-
nent may also cause the infiltration of the intestinal wall 
and perforation of the viscera (Figure 5-6).
Indeed, in one case in literature, the mesenteric 
panniculitis appeared as a multiple, fibrotic masses in 
the peritoneal cavity, mimicking a peritoneal carcino-
matosis (40). 
At this point, we must remember the usefulness 
of imaging to identify the complications of mesenteric 
panniculitis. In fact, the radiological methods allow to 
define the extent of the disease and the possible oc-
clusive, perforative and ischemic intestinal complica-
tions more frequently related to the fibrotic infiltration 
or traction. In this context, the correct radiological 
evaluation of the pathology and the relationships with 
neighboring structures is fundamental for a correct 
therapeutic planning.
In the medical literature the radiological features 
of mesenteric panniculitis are described mainly on 
computed tomography images. Few are the articles 
in which the mesenteric panniculitis is described on 
magnetic resonance images. In general, the intensity of 
the signal at MRI varies depending on the histological 
components and stage of the disease. The inflamma-
tory form of mesenteric panniculitis is usually hypoin-
tense in T1 weighted images and hyperintense in T2 
weighted sequences. When the fibrosis is predomi-
nant, the disease appears as a localized mass of fibrous 
tissue, hypointense in both T1 and T2 sequences. The 
pseudocapsule appears usually as a hypointense sharp 
around the mass. Delayed contrast enhancement is 
characteristic and indicates the presence of fibrous tis-
sue (39, 41) (Figure 7-8).
In our experience the mesenteric panniculitis on 
MRI images appeared as a mesenteric mass hypoin-
tense in T1 and hypointense to hyperintense in T2 se-
quences. The pseudocapsule appeared as a hypointense 
fibrotic sharp around the mass. The best sequence to 
detect the mesenteric panniculitis was the fat saturated 
T2 sequences in which the mesenteric panniculitis was 
Figure 3. An axial CT image shows a mesenteric panniculitis 
with a fibrotic band around the mass (pseudocapsule sign/red 
arrow) and a rim of preserved fat around vessels and lymph 
nodes (the fat ring sign/yellow arrow). The mesenteric vessels 
are engulfed
Figure 4. The axial contrast enhanced CT image shows a large 
mesenteric mass with a pseudocapsule (yellow arrow), lymph 
nodes and vessels inside the mass and displacement of the sur-
rounding bowel
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Figure 5. An axial contrast enhanced CT image shows a mesen-
teric mass with a fibrotic portion with mild retraction of small 
bowel (red arrow). The mass is compatible with the retractile 
form of mesenteric panniculitis
Figure 6. The CT image shows a retractile panniculitis. In this 
case the fibrotic portion of the mass cause an important retrac-
tion on the adiacent small bowel (red arrow). The description of 
small bowel retraction due to fibrotic mesenteric panniculitis is 
the most important aspect of the disease because it can influ-
ence the prognosis and treatment of the disease in relation to 
the symptomatology of intestinal obstruction
Figure 7. An axial T2 weighted image showed the presence of a 
mass with a hypointense pseudocapsule (black arrow). Note the 
enlarged lymph nodes inside the mass
Figure 8. An axial T1 weighted image shows the presence of 
a hypointense mesenteric mass with the classical hypointense, 
fibrotic pseudocapsule around the mass (red arrow). The fat 
around vessels and lymhp nodes within the mass has the same 
intensity of the normal fat (the fat ring sign)
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easily identified after the saturation of the mesenteric 
fat as a high signal mass (Figure 9-10). The mesenteric 
panniculitis did not show a significant restriction of dif-
fusion on diffusion weighted images (DWI) and ADC 
map (Figure 11-12). Although, the mesenteric mass 
showed a delayed enhancement after injection of gado-
linium due to its predominant or partial fibrotic nature, 
like reported in literature (Figure 13).
Figure 9. An axial T2 fat saturated  image of abdomen shows 
the presence of a hyperintense mesenteric mass in the root of 
mesentery with a pseudocapsule around the mass
Figure 10. An axial T2 fat saturated image shows the presence 
of a large, hyperintense  mesenteric panniculitis. The solid com-
ponent is preponderant and the pseudocapsule and the fat ring 
sign are not clearly visible in this case
Figure 11. The mesenteric panniculitis does not show a restric-
tion of diffusion on DWI image (red arrow)
Figure 12. The ADC map in the same patient confirmed the 
absence of a significant restriction of diffusion (red arrows)
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Differential diagnosis
The differential diagnosis of mesenteric pannicu-
litis includes various conditions. Mesenteric oedema, 
hemorrhage, lymphedema, inflammation and mesen-
teric neoplasia may mimick mesenteric panniculitis 
(37).  The mesenteric oedema occurs in patients with 
hepatic cirrhosis, cardiac failure, renal failure, hypo-
proteinemia, bowel ischemia, venous thrombosis and 
primary or secondary tumors involving the mesentery 
or abdominal inflammatory disease such as pancreati-
tis, appendicitis and diverticulitis (37). The mesenteric 
oedema may be associated with subcutaneous fluid and 
ascites and, in these cases, the mesenteric oedema is 
usually related to a systemic disease.  When the mes-
enteric oedema is associated with venous thrombosis, 
the oedema is usually focal and localized around the 
vessels occluded (42). However, it is interesting to 
note, that the conditions of acute inflammation could 
lead to chronic inflammation and chronic degenera-
tion of the mesentery that could be considered a sec-
ondary form of mesenteric panniculitis.
The mesenteric hemorrhage is usually traumatic, 
iatrogenic or may be related with intraperitoneal tu-
mor rupture. However, the differential diagnosis is not 
difficult because the mesenteric hemorrhage shows a 
density between 40-60HU and a high signal intensity 
in T1 weighted images.
Another disease which may mimick the mesen-
teric panniculitis is the peritoneal tuberculosis. The 
disease usually appears as a multiple nodularities of 
the mesenteric fat, thickening of the peritoneum with 
ascites and enlarged lymph nodes. However, the tuber-
culosis usually involves various part of the peritoneum 
like the omentum, spleen and liver, and the lymph 
nodes have a hypodense necrotic core, sometimes cal-
cific (42, 43).
Among the tumors, the most common neoplas-
tic process of mesentery is non Hogdkin lymphoma 
and 30-50% of non Hogdkin lymphoma harbouring 
in the mesenteric lymph nodes (44). The non Hogdkin 
lymphoma presents three main radiologic pattern due 
to coalescence of lymphomatous lymph nodes and/
or mesenteric lymphomatous infiltration, which may 
mimick the mesenteric panniculitis: multiple, rounded, 
mildly enhancing, homogeneous masses that often en-
case the mesenteric vessels and produce the“sandwich 
sign”; a large  heterogeneous mass with low-attenua-
tion areas of necrosis; an ill-defined infiltration of the 
mesenteric fat with sometimes the fat ring sign around 
the vessels (37, 42, 44, 45). However, if multiple, large 
lymph nodes are visualizable with diffuse and irregular 
fat infiltration, which increase at imaging follow-up, 
the lymphoma must be the first hypothesis. In this 
context, the use of PET/CT is included in the differ-
ential diagnosis between mesenteric panniculitis and 
abdominal lymphoma with mesenteric involvement. 
In the study of Zissin et al., 33 PET/CT were evalu-
ated in 19 oncological patients with mesenteric altera-
tions morphologically due to mesenteric panniculitis 
and the uptake of mesenteric nodules was studied. In 
11 patients, fluorodeoxyglucose uptake (FDG) was 
negative and remained negative at subsequent controls 
and therefore the authors concluded with certainty for 
a condition of benignity possibly due to a mesenteric 
panniculitis. The remaining 8 patients had a suspected 
FDG uptake and in 7 patients an underlying neoplasia 
was found (6 with abdominal lymphoma and 1 with 
Figure 13. This axial contrast enhanced MRI image of abdo-
men during the late phase shows the presence of a mesenteric 
mass with contrast enhancement. The contrast enhancement is 
typically more evident in the late phase and more evident in the 
forms with a greater fibrotic component or in the  fibrotic por-
tions of the mass such as the pseudocapsula
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relapsing metastatic cervical tumor) (46). Along the 
same lines are Coulier B et al., according to which the 
absence of FDG uptake at PET/CT has a high ac-
curacy in excluding a lymphomatous or carcinomatous 
neoplastic disease. In fact, the PET/CT is useful for 
the identification of mesenteric deposits or manifesta-
tions of neoplastic pathologies even in patients with 
a mesenteric panniculitis-like pathology and it is also 
useful for evaluating a possible subsequent onset of the 
disease. However, it must be considered that PET can 
be non-specific and an increase in uptake can be due to 
inflammatory forms such as sarcoidosis (47).
The appearance of carcinoid tumor and rectractile 
panniculitis can be identical.  Both can appear as an ill-
defined, infiltrating soft-tissue mass with calcification 
and desmoplastic reaction. However, the preservation 
of the fat around vessels and lymph nodes directs the 
diagnosis towards the mesenteric panniculitis. Al-
though, the carcinoid tumor may be associate with a 
hypervascular bowel mass or hepatic metastasis (36).
The peritoneal carcinomatosis and peritoneal 
mesothelioma may simulate the sclerosing mesenteri-
tis when soft tissue implants and lymphadenomegaly 
are localized in the mesentery. Calcifications may be 
present in both tumors. However, in these conditions 
we observe usually an extensive involvement of the 
peritoneum, with peritoneal thickening and ascites. 
These features are not typical for mesenteric pannicu-
litis (36).
Conclusion
The mesenteric panniculitis is a rare disease of the 
mesentery. In most cases it is asymptomatic and its 
identification is occasional and occurs during the ex-
ecution of diagnostic exams,  performed for other rea-
sons. When the disease is symptomatic, the symptoms 
are mainly abdominal pain and dyspepsia, however, in 
a small percentage it may produce intestinal obstruc-
tion and requiring surgery.
From a radiological point of view, the diagnosis 
of mesenteric panniculitis can be suspected whenever 
a mass is found in patients with abdominal symptoma-
tology or not, in the root of the mesentery, character-
ized by dislocation of the surrounding structures, in-
flammation and variable fibrosis of the mesenteric fat, 
with a selective sparing of the fat around the vessels 
and the lymph nodes and with a fibrotic pseudocapsule 
around the lesion itself. This mass may also have a pre-
dominantly fibrotic and solid appearance and may de-
termine traction or infiltration of the intestinal loops 
with their occlusion or perforation.
Therefore, it is important for the radiologist to 
know how to recognize this disease and evaluate its 
relationships with the surrounding structures. 
Regarding the etiology, it is our opinion, endorsed 
by some experiences in literature, that mesenteric pan-
niculitis may be  secondary to various conditions caus-
ing chronic inflammation of the mesentery.
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